Prof Timothy O'Brien

Director of CCMI and REMEDI.



Prof O’Brien is head of the Department of Medicine, director of the Centre for Cell Manufacturing Ireland (CCMI) and the Regenerative Medicine Institute (REMEDI), and dean of the college of Medicine, Nursing and Health Sciences at NUI Galway.

 Prof O’Brien is an endocrinologist whose research is focused on the use of advanced therapy medicinal products, such as cells and genes, for the treatment of diabetic complications.  Many of his 256 peer-reviewed publications focus on this issue.

 Since returning to Ireland following 14 years in the USA, he has established a regenerative medicine research program, led the development of a GMP facility and a Clinical Research Facility in Galway, has been the PI on the first gene and cell therapy trials conducted in Ireland and is a founder of a stem cell company, Orbsen Therapeutics, which has novel and patented stem cell isolation technologies.

Prof O’Brien’s current focus is on translational efforts to evaluate the use of mesenchymal stem cells and repaired endothelial progenitor cells in diabetic complications such as critical limb ischemia.

Research Publications